0.0025 (1.85%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Strong
Garp
Strong
Mqv Small
Neutral
Value
Consensus
Price
Neutral
Earnings
Very Strong
Earnings
Neutral
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Very Weak
Telephone
Address
2nd Floor, 13-15 Bouverie Street, Harmsworth House, London, Greater London EC4Y 8DP
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.09 - 0.21
Trade Value (12mth)
US$3,653.00
1 week
-3.57%
1 month
-10%
YTD
-6.9%
1 year
28.57%
All time high
1.52
EPS 3 yr Growth
-105.10%
EBITDA Margin
11.00%
Operating Cashflow
£5m
Free Cash Flow Return
55.60%
ROIC
13.20%
Interest Coverage
5.60
Quick Ratio
1.60
Shares Outstanding (Fully Diluted)
367m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
GBP
Short Sell (% of issue)
0.00
| Date | Announcements |
| 11 May 26 | |
| 29 April 26 | |
| 23 April 26 | |
| 16 April 26 | |
| 06 March 26 |
Historical data
Forecast data
| GBP | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | £ |  | | | | -0.03 | -0.02 | N/A | | | | ||
EPS (Fully Diluted) | £ | | | | | -0.03 | -0.02 | N/A | | | | ||
Growth | % | | | | | 55.1 | 37.6 | 118.3 | | | | ||
PE | X | | | | | N/A | N/A | 24.2 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | 7.5 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Months Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
